Trial intelligence / Profile preview

Functional Study of the Hypothalamus in High-resolution MRI in Women With PCOS

NCT03043924Completed

Sponsor
CHU de Lille
Start
Sep 2017
Primary completion
Apr 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label trial of cyproterone and estradiol in polycystic ovary syndrome (PCOS) (2 arms), sponsored by CHU de Lille. Primary endpoint: Apparent Diffusion Coefficient at 3 months. Started Sep 2017; status: completed.

02

Drugs

cyproteroneestradiol
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT03043924.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03043924.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call